RhumbLine Advisers’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$686K Buy
118,896
+13,690
+13% +$79K ﹤0.01% 2461
2025
Q1
$694K Buy
105,206
+5,215
+5% +$34.4K ﹤0.01% 2354
2024
Q4
$871K Buy
99,991
+1,923
+2% +$16.7K ﹤0.01% 2318
2024
Q3
$1.92M Sell
98,068
-6,108
-6% -$119K ﹤0.01% 1937
2024
Q2
$2.14M Sell
104,176
-9,432
-8% -$194K ﹤0.01% 1849
2024
Q1
$2.42M Buy
113,608
+1,545
+1% +$33K ﹤0.01% 1811
2023
Q4
$1.61M Buy
112,063
+1,187
+1% +$17.1K ﹤0.01% 2016
2023
Q3
$1.01M Buy
110,876
+5,260
+5% +$48K ﹤0.01% 2205
2023
Q2
$1.12M Buy
105,616
+1,613
+2% +$17.1K ﹤0.01% 2228
2023
Q1
$1.27M Buy
104,003
+3,300
+3% +$40.4K ﹤0.01% 2021
2022
Q4
$1.25M Buy
100,703
+2,379
+2% +$29.5K ﹤0.01% 2024
2022
Q3
$1.34M Buy
98,324
+6,733
+7% +$92K ﹤0.01% 1985
2022
Q2
$1.68M Buy
91,591
+8,106
+10% +$149K ﹤0.01% 1856
2022
Q1
$1.34M Sell
83,485
-7,131
-8% -$115K ﹤0.01% 2006
2021
Q4
$1.27M Sell
90,616
-1,124
-1% -$15.7K ﹤0.01% 2112
2021
Q3
$1.72M Buy
91,740
+2,900
+3% +$54.3K ﹤0.01% 1990
2021
Q2
$1.85M Buy
88,840
+21,248
+31% +$443K ﹤0.01% 1988
2021
Q1
$1.91M Sell
67,592
-2,498
-4% -$70.6K ﹤0.01% 1943
2020
Q4
$2.29M Buy
70,090
+7,091
+11% +$232K ﹤0.01% 1791
2020
Q3
$1.93M Sell
62,999
-8,360
-12% -$256K ﹤0.01% 1700
2020
Q2
$1.16M Buy
71,359
+28,878
+68% +$471K ﹤0.01% 1983
2020
Q1
$423K Buy
42,481
+281
+0.7% +$2.8K ﹤0.01% 2244
2019
Q4
$580K Buy
42,200
+1,739
+4% +$23.9K ﹤0.01% 2297
2019
Q3
$614K Buy
40,461
+2,649
+7% +$40.2K ﹤0.01% 2249
2019
Q2
$745K Buy
37,812
+1,503
+4% +$29.6K ﹤0.01% 2193
2019
Q1
$602K Sell
36,309
-809
-2% -$13.4K ﹤0.01% 2248
2018
Q4
$521K Buy
37,118
+13,781
+59% +$193K ﹤0.01% 2282
2018
Q3
$408K Sell
23,337
-310
-1% -$5.42K ﹤0.01% 2362
2018
Q2
$430K Buy
23,647
+5,552
+31% +$101K ﹤0.01% 2367
2018
Q1
$339K Buy
18,095
+4,160
+30% +$77.9K ﹤0.01% 2377
2017
Q4
$213K Sell
13,935
-910
-6% -$13.9K ﹤0.01% 2596
2017
Q3
$222K Buy
14,845
+746
+5% +$11.2K ﹤0.01% 2680
2017
Q2
$131K Buy
+14,099
New +$131K ﹤0.01% 2864